While a clinical trial with early-stage BC cases (N = 1380) reported that high IL-6 expression was associated with improved BC-specific survival [23], this finding was not consistently reported by other studies included in a meta-analysis (N = 3224 cases) [17]. Here, IL6 is linked to breast cancer.